139 related articles for article (PubMed ID: 2454600)
1. [Problems in the clinical evaluation of interferon].
Zanussi C
Ann Ist Super Sanita; 1987; 23(4):779-85. PubMed ID: 2454600
[No Abstract] [Full Text] [Related]
2. [Therapeutic use of interferon: current trends and prospects].
Laghi V; Toccaceli F
Medicina (Firenze); 1990; 10(2):201-11. PubMed ID: 1703261
[No Abstract] [Full Text] [Related]
3. [Current status of clinical studies of interferon].
Ogawa M
Gan To Kagaku Ryoho; 1983 Jul; 10(7):1717-21. PubMed ID: 6191689
[No Abstract] [Full Text] [Related]
4. [Clinical applications of human interferon].
Ghyka G; Moldovan I
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1987; 32(4):289-304. PubMed ID: 2450396
[No Abstract] [Full Text] [Related]
5. Clinical experiences with interferon-alpha and interferon-gamma.
Steinmann GG; Rosenkaimer F; Leitz G
Int Rev Exp Pathol; 1993; 34 Pt B():193-207. PubMed ID: 8458713
[No Abstract] [Full Text] [Related]
6. [The role of interferons in treating hematopoietic system neoplasms].
Robak T
Pol Tyg Lek; 1994 Mar 21-28; 49(12-13):307-10. PubMed ID: 7528912
[No Abstract] [Full Text] [Related]
7. Potential mechanisms of interferon neurotoxicity.
Bender CM; Monti EJ; Kerr ME
Cancer Pract; 1996; 4(1):35-9. PubMed ID: 8788769
[TBL] [Abstract][Full Text] [Related]
8. Interferons and cancer: what is the present position?
Priestman TJ
Radiography; 1983 Jan; 49(577):17-9. PubMed ID: 6191356
[No Abstract] [Full Text] [Related]
9. [Interferon in the therapy of hemoblastoses (a review)].
Iavorkovskiĭ LI; Iavorkovskiĭ LL
Ter Arkh; 1989; 61(10):33-9. PubMed ID: 2481891
[No Abstract] [Full Text] [Related]
10. [Interferons in hematology].
Elira Dokekias A
Tunis Med; 1992; 70(8-9):387-90. PubMed ID: 1283040
[No Abstract] [Full Text] [Related]
11. Interferons. New additions and indications for use.
Stadler R; Ruszczak Z
Dermatol Clin; 1993 Jan; 11(1):187-99. PubMed ID: 7679614
[TBL] [Abstract][Full Text] [Related]
12. Interferon as therapeutic agent.
Borecký L; Fuchsberger N
Acta Virol; 1983 Jul; 27(4):359-70. PubMed ID: 6195902
[TBL] [Abstract][Full Text] [Related]
13. [Immunotherapy of malignant diseases].
Dorval T; Michon J; Tartour E; Fridman WH
Bull Cancer; 1995; 82 Suppl 2():127s-138s. PubMed ID: 7542946
[TBL] [Abstract][Full Text] [Related]
14. [Phase I-II studies on various types of interferon against malignant tumors].
Mitachi Y; Kambe M; Asamura M; Wakui A
Nihon Gan Chiryo Gakkai Shi; 1988 Jan; 23(1):33-42. PubMed ID: 2454276
[No Abstract] [Full Text] [Related]
15. Interferon therapy.
Alexander MC
NITA; 1987; 10(1):40-2. PubMed ID: 2434885
[No Abstract] [Full Text] [Related]
16. Interferons.
Balkwill FR
Lancet; 1989 May; 1(8646):1060-3. PubMed ID: 2469921
[No Abstract] [Full Text] [Related]
17. Interferon in cancer therapy.
Neefe JR
Am Fam Physician; 1981 Jul; 24(1):129-30. PubMed ID: 6167158
[No Abstract] [Full Text] [Related]
18. Prospects for the medical use of interferon in 1984.
Postic B; Arroyo JC
Henry Ford Hosp Med J; 1984; 32(2):116-22. PubMed ID: 6210270
[No Abstract] [Full Text] [Related]
19. [Interferon: validity, risks, prospects of clinical use].
Rossi GB; Belardelli F
Epidemiol Prev; 1987 Mar; 9(30):13-5. PubMed ID: 2466676
[No Abstract] [Full Text] [Related]
20. Mydriatic eye drops: severe adverse effects in children. Systemic reactions.
Prescrire Int; 2009 Jun; 18(101):123. PubMed ID: 19637434
[No Abstract] [Full Text] [Related]
[Next] [New Search]
